# Linc'well

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/linc-well

- Industry: Software
- Headquarters: Tokyo, Japan
- Website: www.linc-well.com
- Total disclosed funding: $74M
- Latest round: Series C (Nov 23, 2021)
- Investors on record: 6

## About

Linc'well Inc. is a telehealth company providing innovative healthcare solutions to enhance the accessibility and efficiency of medical care through its comprehensive platform.Founded in 2018 by Ryosuke Yamamoto, Linc'well Inc. is headquartered in Tokyo, Japan. The company specializes in telehealth services, offering a platform for medical consultations via smartphones. In November 2021, Linc'well raised JPY 8 billion in Series C funding led by Bain Capital, with participation from Pavilion Capital, DCM, Incubate Fund, and Nissay Capital. This funding round brings the total amount raised to JPY 8 billion and establishes a current company valuation of JPY 31,815.643 million.Linc'well specializes in providing innovative telehealth solutions designed to enhance the accessibility and efficiency of medical care. Their core offerings include a comprehensive telehealth platform that allows patients to engage in medical consultations through their smartphones, from booking appointments to receiving prescriptions. This system caters to a diverse client base, including individual patients seeking convenient healthcare options and medical professionals looking to streamline their practice operations. Furthermore, Linc'well promotes intelligent technology integration at primary care clinics, facilitating appointment management, consultations, payments, and medical records management. The company also engages in the e-commerce of self-care products, such as skincare items and over-the-counter medications, enhancing its service offerings. Linc'well's products are available in various geographical markets, aiming to improve healthcare delivery in urban and suburban areas across North America and select international regions.Linc'well generates revenue through a combination of transaction-based models and service subscriptions tailored for both individual consumers and healthcare providers. The telehealth platform operates on a fee-for-service basis, where patients can choose to pay via credit card at the time of consultation or opt for deferred payment options. Additionally, medical professionals utilizing Linc'well's technology for clinic management may incur subscription fees or transaction fees based on the services rendered. The company's e-commerce segment contributes to revenue by selling self-care products directly to consumers, providing a seamless shopping experience alongside their healthcare services. With a focus on modernizing healthcare access, Linc'well's transaction structures are designed to facilitate efficient interactions between patients and service providers, thereby enhancing the overall healthcare experience.In November 2021, Linc'well Inc. raised JPY 8 billion in Series C funding to support the development of a healthcare platform and the hiring of personnel for new product development. The company plans to expand into additional markets in North America and other regions by leveraging this funding to enhance product offerings and improve healthcare access.

## Funding rounds

- Series C, Nov 23, 2021, $71M — Bain Capital, DCM, Incubate Fund, Pavilion Capital, Nissay Capital
- Series A, May 27, 2019, $3.2M — DCM, Incubate Fund, Sony Innovation Fund
- Seed, Apr 1, 2018, $0.7M — Incubate Fund

## Investors

- Incubate Fund (https://capitalatlas.ai/funds/incubate-fund) — Seed, Series A, Series C
- DCM (https://capitalatlas.ai/funds/dcm) — Series A, Series C
- Sony Innovation Fund (https://capitalatlas.ai/funds/sony-innovation-fund) — Series A
- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series C
- Pavilion Capital — Series C
- Nissay Capital (https://capitalatlas.ai/funds/nissay-capital) — Series C